Since the advent of Manufacturing Execution Systems (MES, or MOM for those who prefer) in the late 1980s, life sciences, and especially pharmaceuticals finishing and packing, led the way in useful MES solutions. Some would argue that MES for pharma has reached maturity and there are few gains to be made. At LNS Research, we believe that change is just beginning and it is time for the pharma software industry to wake up or get severely disrupted by new players.

Many pharmaceutical companies, ranging from boutique startups to the global giants, have active Industrial Transformation (IX) programs that foresee structural changes in the way they operate. Existing pharma MES systems provide the necessary functionality for most operations but are hard to maintain, inflexible, and do not provide a data platform for other parts of the enterprise. Such integration will, inevitably, be a part of IX programs. 

In our 2021 Industrial Transformation (IX) Readiness research, we asked more than 300 industrial companies where they were on their IX journey. Since our 2019 study, the share of companies fully committed to the journey soared from 16% to 28% - crossing the proverbial chasm. Conversely, the share of companies “stuck in pilot purgatory” fell from 13% to 7%. 

LNS Research has been writing about Digital Twins for a number of years. We still find our manufacturing clients confused by the opportunities presented by Digital Twins and unclear on how to proceed. In face of this reality, we wanted to set up a simple framework for thinking about Digital Twin use cases and answer some of the most common questions we hear about these concepts.

LNS Research had the opportunity to participate in ETQ’s virtual event, Quality Vision 2021. The virtual mainstage was dominated by discussion of the company’s concurrent new product release, Reliance NXG, a cloud-native version of Reliance that is reportedly fully functional.

Industrial Transformation (IX) continues to animate manufacturers worldwide. Our 2020 global survey shows that more than three-quarters of companies are executing, piloting, or planning on executing an Industrial Transformation (IX) program in the next 12 months despite a global pandemic. Industrial Transformation Platforms (IX Platforms) are a core component to the majority of IX Leaders who are three times more likely to be implementing an IX Platform as compared to Followers.

Recent moves by some of the market's major players are beginning to confirm what LNS previously identified as a trend toward renewed interest in and a fresh approach to what LNS calls Operational Excellence 4.0 (OE 4.0). We are seeing new partnerships as well as M&A between suppliers of APM, EHS, Quality, and Connected Worker applications.

It’s been nearly three years since LNS Research initiated coverage of the digitally connected industrial worker space with the publication of our seminal research, “The Connected Worker: Mobilize and Empower People to Reduce Risk and Improve Safety”. Since then, we’ve continued to conduct research and develop our point of view on the topic while working closely with a variety of industrial organizations and technology vendors on their connected worker initiatives and solutions.

Seventh Life of MOM - Refined

Almost four years ago, I wrote about the "7 lives of MOM," a vision into the future of MOM architecture, and how it would be deployed. The 7^th life was defined as “No MOM,” where the functionality previously implemented in MOM systems would be distributed as apps across an Industrial IOT (IIoT) platform. This still seems like a good idea to most and the reality is getting closer, but in a different environment than that we had envisioned.

LNS Research’s initial work outlined the three architectural approaches to Industrial Transformation (IX). We also detailed the advantages and disadvantages for industrial users of each of these architectural paths and the underlying IX Infrastructure. We are now extending our research to advanced analytics. So, in this blog, we define Industrial Transformation (IX) Analytics and how LNS classifies its use.

If the adage, “With Change Comes Opportunity” is at all correct, Environment, Health and Safety (EHS) business leaders have opportunity in spades. Entering the second year of the COVID-19 pandemic, change and the ability to adapt to it have become the mantra for industrial organizations to get through the crisis. Over the past year, “resilience” and “agility” were the buzz words of corporate earnings calls and communications, perhaps to the point of overuse regardless of their validity.